Background There are several methods of assessing nutritional status in cancer of which
serum albumin is one of the most commonly used. In recent years, the role of malnutrition as …

BACKGROUND Anemia is common in cancer patients, although the prevalence is
influenced both by the type of malignancy and the choice of treatment. Individual studies …

Purpose: Our understanding of the natural history of renal cell carcinoma, the role of
nephrectomy, the benefits of immunotherapy and the possibilities of new technologies are …

Renal cell carcinoma (RCC) is a disease in which cancer cells form in the tubules of the
kidney. RCC, the incidence of which is increasing annually, represents five percent of adult …

OBJECTIVES: To perform a retrospective study to determine whether survival and
immunotherapy response are related to the site of metastases (lung versus bone) and to the …

PURPOSE: Determination of prognostic factors is essential for the management of renal cell
carcinoma. Stage, histological grade and type, and performance status are now well known …

Introduction: Unresectable renal cell carcinoma (RCC) is a technically incurable condition.
Historically, RCC is resistant to chemotherapy and radiotherapy. Cytokine therapy was until …

BACKGROUND: Pretreatment C-reactive protein (CRP) level has been shown to be
prognostic for metastatic renal cell carcinoma (mRCC). OBJECTIVES: To demonstrate that …

Prognostic and predictive factors in patients with metastatic renal cell carcinoma (MRCC)
have been evaluated from untreated patients or patients on several different treatment …

OBJECTIVES: We retrospectively analyzed the survival of renal cell carcinoma patients with
bone metastases, and identified prognostic factors and a model predictive for survival in …